NEW DELHI: NEW DELHI: The Delhi High Court on Thursday directed US pharmaceutical major Johnson & Johnson (J&J) Pvt Ltd to pay ₹25 lakh each to four patients affected by its faulty acetabular surface replacement (ASR) hip implants. India’s drug regulatory authority had ordered the company to pay compensation to these patients, following the recommendation of an expert committee. The Central Drugs Standard Control Organization (CDSCO) had in March asked Johnson & Johnson to pay Rs. Earlier, J&J had offered the government a fast track process by paying ₹25 lakh to patients of revision surgeries. The company maintained that it was willing to pay only revision surgery patients as was done globally.

Source: Mint May 02, 2019 12:50 UTC